Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.
Irmela MantelMarta ZolaOlivier MirRaphael GaillardFrancine Behar-CohenPublished in: The British journal of ophthalmology (2018)
This study provides evidence that treatment with antidepressant medication increases the anti-VEGF retreatment requirement in patients with nAMD, possibly through the interplay of antidepressant medication, depression status and VEGF levels.